CLINICAL TRIALS PROFILE FOR NORPLANT
✉ Email this page to a colleague
All Clinical Trials for Norplant
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00064766 ↗ | Norplant and Irregular Bleeding/Spotting | Unknown status | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 4 | 2003-02-01 | Irregular or prolonged menstrual bleeding and/or spotting are common side effects in patients using progestin-only hormonal contraception such as levonorgestrel implants (Norplant). Doxycycline, a drug approved by the Food and Drug Administration (FDA) to treat gum disease, may reduce the occurrence of uterine bleeding and spotting in women who use Norplant. This study will evaluate the effects of doxycycline on uterine bleeding/spotting in women using Norplant. |
| NCT00445887 ↗ | Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer | Completed | National Cancer Institute (NCI) | Phase 2 | 2008-03-10 | This randomized phase II trial is studying how well levonorgestrel works in preventing ovarian cancer in patients at high risk for ovarian cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of levonorgestrel may prevent ovarian cancer. |
| NCT00445887 ↗ | Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer | Completed | Gynecologic Oncology Group | Phase 2 | 2008-03-10 | This randomized phase II trial is studying how well levonorgestrel works in preventing ovarian cancer in patients at high risk for ovarian cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of levonorgestrel may prevent ovarian cancer. |
| NCT00563576 ↗ | Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation | Completed | Columbia University | N/A | 2007-09-01 | Many women choose Depo-Provera for birth control because it is easy to use and very effective. However, a significant number of Depo-Provera users experience irregular bleeding during the first 90 days. Many users discontinue after their first injection due to irregular bleeding. This study will evaluate the effect of using an estrogen vaginal ring during the first 90 days of Depo-Provera use to see if it is acceptable to women and whether it decreases irregular bleeding during the first 90 days of use and increases continuation to a second injection. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Norplant
Condition Name
Clinical Trial Locations for Norplant
Trials by Country
Clinical Trial Progress for Norplant
Clinical Trial Phase
Clinical Trial Sponsors for Norplant
Sponsor Name
| Sponsor Name for Norplant | |
| Sponsor | Trials |
| Columbia University | 2 |
| Women and Infants Hospital of Rhode Island | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| [disabled in preview] | 1 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
